PATENT CLAIM ANALYSIS

Application Number: 16153180
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["544", "106000"]

Abstract:
The present invention provides compounds having a CB 1  receptor-binding moiety and a directing moiety. In related aspects, the invention provides pharmaceutical compositions containing compounds of the invention, methods for inhibiting a pathway modulated in part by the CB 1  receptor activity, and methods for treating a condition or disorder mediated in part by CB 1  receptor activity. In certain embodiments, the compounds are compounds of Formula I. Methods of preparing compounds of Formula I are also described. In another aspect, the invention provides methods of identifying a selective agonist of the beta-arrestin pathway over the G-protein pathway.

Claim (Index 3):
The compound of  claim 1 , selected from the group consisting of: and pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 97.0
- Lexical Diversity: 1.96364
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15383922', '14207841', '16050227', '13646143', '12732428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8006032503539663
- 35 USC 102 Novelty (BERT): 0.530971535062033
- Combined Prediction Score: 0.7736400788247729
- Mean Citation Score: 258.800412
- Max Citation Score: 373.49158
- Similarity Product: 332.02281638374086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test